Research progress and challenges to coronavirus vaccine development

J Med Virol. 2021 Feb;93(2):741-754. doi: 10.1002/jmv.26517. Epub 2020 Oct 7.

Abstract

Coronaviruses (CoVs) are nonsegmented, single-stranded, positive-sense RNA viruses highly pathogenic to humans. Some CoVs are known to cause respiratory and intestinal diseases, posing a threat to the global public health. Against this backdrop, it is of critical importance to develop safe and effective vaccines against these CoVs. This review discusses human vaccine candidates in any stage of development and explores the viral characteristics, molecular epidemiology, and immunology associated with CoV vaccine development. At present, there are many obstacles and challenges to vaccine research and development, including the lack of knowledge about virus transmission, pathogenesis, and immune response, absence of the most appropriate animal models.

Keywords: animal model; coronavirus; receptor-binding domain; spike protein; vaccine.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • COVID-19 / immunology
  • COVID-19 / prevention & control*
  • COVID-19 / virology
  • COVID-19 Vaccines / biosynthesis*
  • Camelus
  • Coronavirus Infections / immunology
  • Coronavirus Infections / prevention & control*
  • Coronavirus Infections / virology
  • Cricetulus
  • Disease Models, Animal
  • Humans
  • Macaca mulatta
  • Mice
  • Middle East Respiratory Syndrome Coronavirus / drug effects
  • Middle East Respiratory Syndrome Coronavirus / immunology
  • SARS-CoV-2 / drug effects
  • SARS-CoV-2 / immunology
  • Severe Acute Respiratory Syndrome / immunology
  • Severe Acute Respiratory Syndrome / prevention & control*
  • Severe Acute Respiratory Syndrome / virology
  • Severe acute respiratory syndrome-related coronavirus / drug effects
  • Severe acute respiratory syndrome-related coronavirus / immunology
  • Spike Glycoprotein, Coronavirus / chemistry
  • Spike Glycoprotein, Coronavirus / genetics
  • Spike Glycoprotein, Coronavirus / immunology*
  • Vaccines, Subunit
  • Vaccines, Synthetic / biosynthesis
  • Vaccines, Virus-Like Particle / biosynthesis
  • mRNA Vaccines

Substances

  • COVID-19 Vaccines
  • Spike Glycoprotein, Coronavirus
  • Vaccines, Subunit
  • Vaccines, Synthetic
  • Vaccines, Virus-Like Particle